Mabwell-b
Status: Publicly traded
Direct answer
Mabwell-b is publicly traded on HKSE under the ticker 2493.HK.
Mabwell (Shanghai) Bioscience Co., Ltd., a biopharmaceutical company, engages in the research and development, manufacture, and commercialization of biological products for oncology, immunology, bone disorders, ophthalmology, hematology, and infectious diseases in China and internationally. The company offers MAIWEIJIAN for the treatment of giant cell tumor of bone; MALISHU for the treatment of postmenopausal women...
Can you invest in Mabwell-b?
Yes. Mabwell-b is publicly traded on HKSE under the ticker 2493.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Detailed equity research is provided by MarketSnap.